Jeremy Steele

CEO Control Bionics

[Control Bionics @Control_Bionics]

“Mr. Osaka said that #Neuronode has helped him regain the communication he had once lost. He is spending fulfilling days. This is the look of joy!"
Jeremy Steele, CEO of Control Bionics visited Japan and Kiichi Otsuka, a Neuronode user in Japan, and expressed his gratitude. 🙂😀

[CardioScan Services @cardioscanAU]

In the last of the #Wenckebach case study series, Dr Harry Mond explores several #ECGs with #fascicular Wenckebach AV sequences with a reminder to always question the tracings! Read more: https://t.co/kSc0FM8MF4 #cardiology #epeeps

[Jeremy Steele @Jeremysteele_au]

This is a great result team. Thanks for the continued efforts

[CardioScan Services @cardioscanAU]

Throughout the month of April our focus on quality assurance remained high. Across 10 countries & thousands of tests, we delivered 99.98% reporting accuracy, a 1.37% repeat rate & delivered 99.33% of tests on time. See how we maintain quality: https://t.co/GlUinZCqAv #Cardiology

[CardioScan Asia @CardioscanAsia]

#Holter trends in Asia found #Cardiac Pauses to be the 3rd most common finding affecting all ages. 36% of Pauses were found beyond the first 24hrs of analysis, with the avg day of 1st finding at 1.9 days & the latest finding on day 10. Trial us today: https://t.co/RHjA5CTs2o

[CardioScan Asia @CardioscanAsia]

Comparative data across the UK & Asia shows a strong correlation between longer #Holter studies & later average day of first finding. This analysis suggests longer studies support higher diagnostic yields. Trial our service today: https://t.co/RHjA5CTs2o #Cardiology #ECG

[Jeremy Steele @Jeremysteele_au]

Great having you on the team!

[CardioScan Services @cardioscanAU]

Meet Rebekah, a competitive Equestrian and dedicated Business Development Manager here at CardioScan. With over 5 years of service, Bek's positivity and drive can be recognised in the relationships she builds and the quality of her work. #IWD2021 #Womenintech #Cardiology

[CardioScan Services @cardioscanAU]

Meet Ashleigh, a driven #cardiac tech here at CardioScan and an accomplished athlete passionate about improving heart health. Ash loves a challenge and her passion for #health and #fitness can be recognised throughout every facet of her life. #IWD2021 #Womenintech #CardioTwitter

[Jeremy Steele @Jeremysteele_au]

UK Clinical Lead for CardioScan UK now open for applications on NHS Jobs. Please take a look and share with anyone you might think suitable. https://t.co/3KBt6LKaTl

[CardioScanUK @cardioscanUK]

After extending half its Holters to multiday testing, one #NHS Hospital discovered 20% of patients had significant findings beyond 24hrs. A stark reminder of the potential risk for patients going undiagnosed with traditional Holter testing: https://t.co/Jgz269tV6F #CardioTwitter

[CardioScanUK @cardioscanUK]

One #NHS cardiac unit found 67% of significant findings were detected beyond 24hrs last month, with avg day of first finding at 2.7 days & avg test length of 4.1 days. Multiday analysis continues diagnosing patients after traditional 24hr studies: https://t.co/Jgz269tV6F #epeeps

[Jeremy Steele @Jeremysteele_au]

We are on the look out for talented people to join our growing team, including a Clinical Director for the UK. Please follow the link and join our rapidly growing business https://t.co/KnihN3dGxy

[Cardiac Monitors @cardiacmonitors]

A US cardiac clinic found 60% of significant findings were detected beyond the traditional 24hr Holter study period this month, with the avg day of first finding at 5.6 days. Our data helps clinics assess multiday analysis & its impacts beyond 24hr testing:https://t.co/PfHtkH3NLD

[Jeremy Steele @Jeremysteele_au]

Some great data here. Good outcomes for our customers and their patients

[CardioScanUK @cardioscanUK]

Global #Holter trends last month showed clinics with longer average test lengths also correlated with significant findings that were later on average – showing multiday analysis continues to diagnose patients long after traditional 24hr studies: https://t.co/Jgz269tV6F #HRC2020

[CardioScanUK @cardioscanUK]

Our data insights provide a meaningful way to improve patient pathways and assess the efficacy of multiday analysis. We're 100% transparent about our reporting quality, with monthly reports delivered to customers. How does your service compare? https://t.co/EJIV9jCFOX #HRC2020

[Jeremy Steele @Jeremysteele_au]

@CardiacRFT Looks familiar. Best of luck with the trials

[Jeremy Steele @Jeremysteele_au]

Great stuff guys. This is excellent data worth more debate

[CardioScanUK @cardioscanUK]

While 29% of our UK #NHS Hospitals used traditional 24hr #Holter testing, latest results revealed the first significant finding was found at 2.4 days on average last month. Trial our multiday service: https://t.co/nGR2Qb6wql #cardiotwitter #epeeps #cardioed

[CardioScan Services @cardioscanAU]

How would you report this? Assoc Prof Mond shares this case to delve into unusual and classical patterns of twisted leads in 12-lead ECG, including the double twist, and shares the tell-tale footprints of all! Read full article: https://t.co/eavDBpiwUi #cardiotwitter #epeeps

[Jeremy Steele @Jeremysteele_au]

Great data guys

[CardioScanUK @cardioscanUK]

40% of significant findings at #NHS Hospitals this month were detected beyond the traditional 24hr #Holter study, with the average day of first finding at 2.4days. Trial our service: https://t.co/xHsXhhUB3f #epeeps #cardioed

[Jeremy Steele @Jeremysteele_au]

Lots going on with our team in the UK, please follow to be kept up to date.

[CardioScan Services @cardioscanAU]

Our UK Twitter is now live, be sure to follow us for regular UK specific content, news and updates at @cardioscanUK #CardioTwitter #Cardiology

[CardioScan Services @cardioscanAU]

We audit 100% of the 500k+ cardiac reports we deliver to our customers each year. And we openly share the results each month. Learn more about how we maintain our operating standards here: https://t.co/wkIVDDQR9Q #cardiotwitter #epeeps #cardioed #ecg